ABBV
AbbVie Inc
Biotechnology
AbbVie Inc (ABBV) Financials
Annual revenue, profit, EPS and free cash flow for ABBV, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $16.6B | $12.1B | $15.1B | $1.8B | $1.02 | $17.8B |
| FY2024 | $15.1B | $10.7B | $9.1B | $-22.0M | -$0.02 | $17.8B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.